← Back to all reports

AU · COR · C1841

Pharmaceutical Product Manufacturing in Australia

Published 2026-04-02

Data Source

IBISWorld API

💡 This data is served live via the IBISWorld API — embed it in your CRM, portal, or internal tool with a few lines of code.

Key Metrics · 2026

Revenue

$12,325.5M

5yr hist.
▼ 1.8%
5yr fcast
▲ 2.2%

IVA

$3,697.6M

5yr hist.
▼ 1.4%
5yr fcast
▲ 2.2%

Employment

17,654

5yr hist.
▲ 1.9%
5yr fcast
▲ 2.5%

Wages

$2,249.0M

5yr hist.
▲ 2.0%
5yr fcast
▲ 3.1%

Profit

$1,207.9M

5yr hist.
▼ 5.6%
5yr fcast
n/a

Profit Margin

9.8%

5yr hist.
▼ 2.1%
5yr fcast
n/a

Executive Summary

5-Year Outlook

Forecast

Revenue Trend

Cost Structure

All Highlights

Metric Value Hist.
Depreciation / Wages 0.1 ▼ 7.2%
IVA / Revenue 30.0% ▲ 0.7%
Imports/ Demand 72.8% ▲ 5.9%
Exports/ Revenue 39.4% ▲ 0.2%
Revenue per Employee $698,170 ▼ 3.7%
Wages/ Revenue 18.2% ▲ 3.2%
Employees per Establishment 25 ▼ 0.2%
Average Wage $127,393 ▲ 0.1%
Revenue per Enterprise $20.6M ▼ 4.7%
Employees per Enterprise 30 ▼ 1.1%
Establishments per Enterprise 1 ▼ 0.9%
Revenue $12,325.5M ▼ 1.8%
IVA $3,697.6M ▼ 1.4%
Establishments 703 ▲ 2.1%
Enterprises 599 ▲ 3.0%
Employment 17,654 ▲ 1.9%
Exports $4,854.5M ▼ 1.7%
Imports $20,022.4M ▲ 3.8%
Wages $2,249.0M ▲ 2.0%
Profit per Enterprise $2,016,526 ▼ 8.4%
Profit $1,207.9M ▼ 5.6%
Profit Margin 9.8% ▼ 2.1%
Debt / Net Worth 0.1 n/a
Trade Receivables (%) 4.3 n/a
Cash Flow Coverage Ratio 1.6 n/a